Home

Event Details


Q2 2011 Tengion Inc Earnings Conference Call
Tuesday, August 9, 2011 5:00 p.m. ET  
Webcast Presentation
Click here for webcast
Add to CalendarHelp Help
Add to Calendar Click here to add this event to your calendar

Event Details
TitleQ2 2011 Tengion Inc Earnings Conference Call
Date and TimeTuesday, August 9, 2011 5:00 p.m. ET  
Investor Resources
TNGN(Common Stock)
ExchangeOTC BB (US Dollar)
Price$0.16
Change (%) Stock is Down 0.02 (11.11%)
Volume40,527
Data as of 07/24/14 4:00 p.m. ET
Minimum 20 minute delay
Refresh quote
What's New
May 15, 2014
Tengion Reports First Quarter 2014 Financial Results
WINSTON-SALEM, N.C., May 15, 2014 (GLOBE NEWSWIRE) -- Tengion, Inc. (OTCQB:TNGN), a leader in regenerative medicine, today reported its financial results for the first quarter ended March 31, 2014. "We are actively continuing patient enrollment in our ongoing Phase 1 clinical trials for the Neo-Kidney Augment in both Sweden and in the United States. We are also working with key opinion leaders to determine future development plans for the Neo-Urinary Conduit," commented John L. Miclot, Presi... 
March 26, 2014
Tengion Reports Fourth Quarter and Full Year 2013 Financial Results
WINSTON-SALEM, N.C., March 26, 2014 (GLOBE NEWSWIRE) -- Tengion, Inc. (OTCQB:TNGN), a leader in regenerative medicine, today reported its financial results for the fourth quarter and full year ended December 31, 2013 and provided a business update. "We made important progress on our two lead clinical programs over the last year. We now have two Phase 1 clinical trials ongoing for the Neo-Kidney Augment, one in Sweden and the other recently initiated in the U.S. to implant up to 12 patients. ...